Extended hepatitis C treatment after liver transplant may benefit patients
Extending hepatitis C treatment for liver transplant patients beyond current standards results in high clearance rates of the hepatitis C virus from the blood, and a low relapse rate, according to a study by Henry Ford Hospital. "We found that patients who achieved a sustained virological response were more likely to have had extended treatment after transplant," says Matthew Moeller, M.D., gastroenterology fellow at Henry Ford Hospital and lead author of the study.
"In the study, we saw a trend toward decreased mortality as sustained virological response was found to be associated with a 100 percent five-year survival rate vs. 86 percent for those without."
Although, statistically insignificant, the trend could show significance with longer follow-up and a larger sample size, explains Dr. Moeller.
Study results will be presented May 2 at the Digestive Diseases Week conference in New Orleans.
The study looked at 241 consecutive liver transplant patients from 1999-2006. Patients were offered treatment if they tested positive for hepatitis C, had recurrent hepatitis C with at least Stage I fibrosis on biopsy, and stable immunosuppression for a minimum of three months. Patients received either non-pegylated interferon tiw or pegylated interferon weekly in combination with ribavirin.
Of the study patients with hepatitis C, 66 were eligible for treatment, and 22 achieved sustained virological response. Only two patients (8 percent) relapsed. This is in contrast to typical relapse rates of 30-35 percent in non-transplant patients treated with standard therapy. Genotype 1 patients failed more than genotype 2 or 3 patients in achieving sustained virological response (27 percent vs. 70 percent).
Dr. Moeller notes that 35 percent of patients who went on to achieve sustained virological response first became virus-negative at or following week 24.
"Our results suggest that even if patients are positive at week 24, there is still a 35 percent chance that they can achieve sustained viral clearance with extended treatment," says Dr. Moeller.
Source: Henry Ford Health System
- Extending treatment after liver transplant may benefit patients with hepatitis C recurrenceSat, 31 Oct 2009, 14:16:23 EDT
- Donor race may impact recurrent hepatitis C in liver transplant patientsSat, 30 Oct 2010, 10:01:12 EDT
- Drug cocktail offers new hope for hepatitis C patientsWed, 30 Mar 2011, 18:04:10 EDT
- Henry Ford Hospital study: Donor Risk Index does not impact outcomes on a small scaleMon, 16 Aug 2010, 11:43:45 EDT
- Transplanted fatty livers associated with worse prognosis for patients with HCVTue, 13 Jan 2009, 13:36:05 EST
Articles on the same topic
- Some patients with hepatitis B faring better after liver transplantTue, 4 May 2010, 21:33:45 EDT
- Study shows liver transplant center impacts patient outcomesSun, 2 May 2010, 19:52:12 EDT
- Extended hepatitis C treatment after liver transplant may benefit patientsfrom Science DailyThu, 6 May 2010, 2:31:27 EDT
- Some patients with hepatitis B faring better after liver transplantfrom Science CentricWed, 5 May 2010, 7:31:40 EDT
- Some patients with hepatitis B faring better after liver transplantfrom PhysorgWed, 5 May 2010, 5:50:39 EDT
- Study shows liver transplant center impacts patient outcomesfrom PhysorgMon, 3 May 2010, 6:41:33 EDT
- Extended hepatitis C treatment after liver transplant may benefit patientsfrom Science CentricMon, 3 May 2010, 5:20:51 EDT
- Study shows liver transplant centre impacts patient outcomesfrom Science CentricMon, 3 May 2010, 5:20:32 EDT
- Study shows liver transplant center impacts patient outcomesfrom Science BlogSun, 2 May 2010, 20:51:04 EDT
- Researchers make advances in understanding causes, treatments and outcomes of liver diseasefrom Science BlogSun, 2 May 2010, 15:20:24 EDT
- Extended hepatitis C treatment after liver transplant may benefit patientsfrom PhysorgSun, 2 May 2010, 13:51:15 EDT
- Extended hepatitis C treatment after liver transplant may benefit patientsfrom Science BlogSun, 2 May 2010, 9:31:02 EDT